| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -14,6 k € | -145.4% | 32,1 k € | -92.9% | 451,1 k € | +2266.8% | -20,8 k € | -435.3% | -3,9 k € | -195.4% | 4,1 k € | +104.5% | -90,5 k € | -3768.9% | 2,5 k € | +124.4% | -10,1 k € | +86.9% | -77,0 k € | +29.6% | -109,4 k € | |
| EBITDA | -19,7 k € | -164.7% | 30,5 k € | -92.6% | 410,9 k € | +2030.5% | -21,3 k € | -388.7% | -4,4 k € | -221.1% | 3,6 k € | +103.8% | -93,7 k € | -7.8% | -86,9 k € | -720.7% | -10,6 k € | +91.4% | -123,7 k € | +8.8% | -135,6 k € | |
| Operating profit | -21,1 k € | -172.3% | 29,2 k € | -92.9% | 410,1 k € | +2026.7% | -21,3 k € | -388.7% | -4,4 k € | -221.1% | 3,6 k € | +103.8% | -94,0 k € | -7.6% | -87,4 k € | -725.0% | -10,6 k € | +91.4% | -123,7 k € | +10.6% | -138,3 k € | |
| Profit/loss | 2,1 k € | -89.4% | 19,8 k € | -95.2% | 412,5 k € | +1996.0% | -21,8 k € | -350.4% | -4,8 k € | -254.9% | 3,1 k € | +103.3% | -94,6 k € | -7.3% | -88,2 k € | -703.2% | -11,0 k € | +91.0% | -121,6 k € | +12.1% | -138,4 k € | |
| Equity | 269,8 k € | +0.8% | 267,7 k € | +8.0% | 247,8 k € | +250.5% | -164,7 k € | +58.1% | -393,0 k € | -1.2% | -388,1 k € | +0.8% | -391,2 k € | -31.9% | -296,7 k € | -42.3% | -208,5 k € | -5.6% | -197,5 k € | -160.2% | -75,9 k € | |
| Total assets | 795,4 k € | +91.6% | 415,2 k € | -39.9% | 690,7 k € | +184.6% | 242,7 k € | +2785.5% | 8,4 k € | -25.6% | 11,3 k € | +98.4% | 5,7 k € | -86.8% | 43,1 k € | -9.1% | 47,4 k € | -18.0% | 57,8 k € | -15.2% | 68,1 k € | |
| Cash | 7,6 k € | -96.6% | 223,5 k € | +252.1% | 63,5 k € | -73.6% | 240,3 k € | +2843.0% | 8,2 k € | -23.7% | 10,7 k € | +583.5% | 1,6 k € | -37.7% | 2,5 k € | -94.6% | 46,3 k € | +787.6% | 5,2 k € | -90.3% | 53,8 k € | |
| Debts | 525,6 k € | +256.4% | 147,5 k € | -66.5% | 440,9 k € | +8.2% | 407,4 k € | +1.5% | 401,4 k € | +0.5% | 399,4 k € | +0.6% | 396,9 k € | +16.8% | 339,7 k € | +32.8% | 255,9 k € | +0.2% | 255,3 k € | +77.3% | 144,0 k € | |
| Staff | — | — | — | — | — | — | — | 0,9 | — | 0,5 | 0,6 | |||||||||||
Public limited company · Gent · incorporated on 20/08/2013
Public limited company profitable and well capitalised. Cash position declining (-96.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Plant Bio Technologies is a Public limited company incorporated in 2013. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette